Drug intelligence / Profile preview

alternol

Development stage
Preclinical
Lead developer
Ningbo University
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Alternol is a **natural small molecule** isolated from the fermentation of a mutant fungus, *Alternaria alternata* var. *monosporus*, found in Taxus brevifolia bark. It exhibits **broad-spectrum anti-cancer activity** by inducing reactive oxygen species (ROS), causing cell cycle arrest and apoptosis specifically in cancer cells, largely sparing non-cancerous cells[1][2][4]. Key mechanisms involve activation of xanthine oxidase (leading to ROS accumulation), interaction with mitochondrial ATP-producing proteins (resulting in ATP depletion), and induction of both intrinsic and extrinsic apoptotic pathways—including upregulation of death receptor 5 (DR5) via CHOP transcription factor activation and JNK pathway, as well as downregulation of antiapoptotic proteins (such as XIAP, survivin, Bcl-2, Mcl-1)[2]. Preclinical studies confirm efficacy in various cancer cell lines and animal xenograft models, with a favorable safety profile and high therapeutic index[1][2][3][4]. Alternol also promotes differentiation in melanoma cells by upregulating enzymes like tyrosinase, TRP-1, and TRP-2[3].

Other names
alternolalteronol
02

Targets

BCL-2 (BCL-2 family)ChoP (Phosphorylcholine)BIRC5 (Survivin)ATP SynthaseXO (Xanthine Oxidoreductase)TNFRSF10B (DR5)

Beyond the preview

Go deeper on alternol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alternol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call